EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical use and radiological yield of magnetic resonance fingerprinting in epilepsy

Maksim Parfyonov iD, Ting-Yu Su iD, Joon Yul Choi, Ingmar Blümcke iD, Ken Sakaie iD, Spencer Morris iD, Hiroatsu Murakami iD, Andreas Alexopoulos iD, Imad Najm iD, Dan Ma iD, Stephen E Jones iD, Zhong Irene Wang iD

Epilepsia · 2026

DOI: 10.1002/epi.70203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Maksim Parfyonov und 11 weiteren Autor:innen. Beteiligte Einrichtung: Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Epilepsy, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Magnetic resonance fingerprinting (MRF) is a novel paradigm for magnetic resonance imaging (MRI) that efficiently generates multiparametric quantitative tissue property maps with a single acquisition. Its quantitative nature offers many advantages over conventional MRI. Although interest in MRF for epilepsy research has grown in recent years, systematic evaluation of its radiological and clinical value as a supplementary imaging modality is limited.

Methods

We reviewed the diagnostic utility of MRF imaging for 100 epilepsy patients undergoing presurgical evaluation. MRF quantitative maps (T1, T2, gray matter fraction, and white matter fraction) were generated and reviewed alongside conventional MRI. MRF findings were classified as (1) consistent—MRF findings the same as conventional MRI; (2) additional—MRF revealed findings beyond those seen on conventional MRI; or (3) discrepant—findings on conventional MRI not reproduced on MRF. We further stratified results by radiological diagnosis or pathology if available. Observations were further classified based on whether T1 or T2 MRF maps provided greater diagnostic utility.

Results

MRF revealed additional findings in a total of 46 patients (46/100, 46%). In one patient, findings on conventional MRI were not recapitulated on MRF (1/100, 1%). In the remaining 53 patients, MRF findings were consistent with conventional MRI (53/100, 53%). Additional benefits of MRF included the following: improved lesion conspicuity ( n = 16), improved visualization of lesion extent ( n = 11) or asymmetry between bilateral mesial temporal regions ( n = 9), differentiation between multiple lesions ( n = 5), new lesion identified ( n = 2), and visualization of connection between lesion and other areas ( n = 1). Added value from MRF was particularly common in patients with focal cortical dysplasia (FCD) type IIa ( p = .009 vs. FCD IIb) and periventricular nodular heterotopia. Significance Our findings demonstrate the additional yield from MRF in the identification and definition of the extent of epileptogenic lesions, underscoring its potential as a valuable adjunct in presurgical epilepsy evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingEpilepsyBrainHumansFemaleMaleAdultYoung AdultAdolescentFocal Cortical DysplasiaChildMiddle AgedGray MatterBrain Mapping

Stichwörter der Autor:innen

MR fingerprintingPVNHepilepsy surgeryfocal cortical dysplasiaperiventricular nodular heterotopiaquantitative MRI

Autor:innen und Institutionen

  • Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Biomedical Engineering, Yonsei University, Wonju, Republic of Korea.
  • Neuropathologisches Institut, Universitätsklinikum Erlangen and partner of the European Reference Network EpiCARE, Friedrich-Alexander Universität Erlangen-Nuremberg, Erlangen, Germany.
  • Department of Radiology, Diagnostics Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Departments of Neurosurgery and Biomedical Engineering, Duke University, Durham, North Carolina, USA.

ORCID-Profile: Maksim Parfyonov, Ting-Yu Su, Ingmar Blümcke, Ken Sakaie, Spencer Morris, Hiroatsu Murakami, Andreas Alexopoulos, Imad Najm, Dan Ma, Stephen E Jones, Zhong Irene Wang

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Parfyonov, M., Su, T. Y., Choi, J. Y., Blümcke, I., Sakaie, K., Morris, S., Murakami, H., Alexopoulos, A., Najm, I., Ma, D., Jones, S. E., & Wang, Z. I. (2026). Clinical use and radiological yield of magnetic resonance fingerprinting in epilepsy. Epilepsia. https://doi.org/10.1002/epi.70203

Vancouver

Parfyonov M, Su TY, Choi JY, Blümcke I, Sakaie K, Morris S, et al. Clinical use and radiological yield of magnetic resonance fingerprinting in epilepsy. Epilepsia. 2026. doi:10.1002/epi.70203

BibTeX
@article{Parfyonov2026,
  author = {Parfyonov, Maksim and Su, Ting-Yu and Choi, Joon Yul and Blümcke, Ingmar and Sakaie, Ken and Morris, Spencer and Murakami, Hiroatsu and Alexopoulos, Andreas and Najm, Imad and Ma, Dan and Jones, Stephen E and Wang, Zhong Irene},
  title = {Clinical use and radiological yield of magnetic resonance fingerprinting in epilepsy},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1002/epi.70203}
}
Kostenlos starten →